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Over the past decade, continent urinary diversion, especially orthotopic bladder sub-
stitutions, has become increasingly popular following radical cystectomy for bladder 
cancer. The ultimate goal of orthotopic bladder substitution is to offer patients the best 
quality of life, similar to that of patients with native bladders. To achieve that purpose, 
surgeons should be familiar with the characteristics of good candidates for neobladders, 
the possible intraoperative and postoperative problems related to the surgery, and the 
solutions to these problems. Postoperative surveillance and instructions given to the 
patients also contribute to successful, functional results. Here, we reviewed the in-
dications, pitfalls, and solutions for orthotopic bladder substitutions and the patients’
quality of life after surgery. When performed properly, orthotopic continent diversion 
offers good quality of life with few long-term complications. Therefore, we believe it is 
the best option for the majority of patients requiring cystectomy.
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INTRODUCTION
Radical cystectomy (RC) and urinary diversion have been 
the standard treatment of high-grade, invasive transi-
tional cell carcinoma of the bladder. Ideal urinary diversion 
after RC should be the safest for cancer control, have the 
fewest complications, and provide the easiest adjustment 
for patients’ lifestyle, thereby supporting the best quality 
of life (QoL). Over the past decades, since the introduction 
of orthotopic bladder substitution (OBS) by Camey and Le 
Duc in the late 1970s, orthotopic urinary diversion has been 
increasingly performed in both sexes.
　Today, the proportion of cystectomy patients receiving 
a neobladder has increased to 50% to 66% at large-volume 
institutes [1-3]. In this article, we review the published re-
sults regarding OBS using ileum, which is the most com-
monly performed procedure for continent urinary diversion, 
specifically focusing on the indications, preoperative and 
intraoperative considerations, possible problems and sol-
utions, and postoperative QoL of the patients.
PATIENT SELECTION: INDICATIONS AND 
CONTRAINDICATIONS 
Appropriate patient selection for OBS is one of the keys to 
success. All cystectomy patients are possible candidates for 
a neobladder. Nowadays, although contraindications for 
OBS are fewer than in the past, it is important to identify 
patients in whom OBS may be less ideal (Table 1). Before 
determining the urinary diversion method, surgeons 
should consider the patient’s preferences and general per-
formance status, renal and hepatic function, primary tu-
mor stage and location, and the need for adjuvant therapy.
　The primary patient factor for OBS is the patient’s desire 
for a neobladder. The patient should have a certain motiva-
tion to tolerate the initial, and sometimes lasting, incon-
veniences of nocturnal incontinence associated with a neo-
bladder [4]. If patients lack the motivation to understand 
the new voiding techniques that will be required post-
operatively, OBS is not desirable. Thus, the ileal conduit 
is preferred in patients with inadequate intellectual ca-
pacity, dexterity, or physical conditions that impede self- Korean J Urol 2011;52:233-240
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TABLE 1. Contraindications for orthotopic bladder substitution
using ileum
Absolute
Permanently compromised renal function: serum Cr ＞2 mg/dl
or GFR ＜40-50 ml/min
Severe hepatic dysfunction
Inadequate intellectual capacity, dexterity, or mobility
When simultaneous urethrectomy is indicated on the basis of
primary tumor
Relative
Compromised intestinal function, especially inflammatory
bowel disease
Recurrent urethral stricture
Noncompliance of patient to indefinite follow-up
catheterization.
　OBS is contraindicated in patients with permanently 
compromised renal function or severe hepatic dysfunction. 
OBS is absolutely contraindicated in patients with a glo-
merular filtration rate of less than 40-50 ml/min or serum 
creatinine greater than 2 mg/dl as a result of long-standing 
obstruction or chronic renal failure [5]. However, some pa-
tients with significant creatinine elevations due to bladder 
cancer can recover sufficient renal function to allow OBS 
if the obstruction is relieved. In this situation, placement 
of percutaneous nephrostomy before surgery may give 
more accurate information on true renal function. Severe 
hepatic dysfunction is also a contraindication to OBS be-
cause absorption of ammonia from the urine into the portal 
circulation markedly increases postoperatively through 
the intestinal mucosa of the neobladder, leading to hyper-
ammonemia. In addition, OBS is relatively contraindica-
ted in patients with compromised intestinal function, par-
ticularly inflammatory bowel disease.
　OBS is also absolutely contraindicated in patients who 
are candidates for simultaneous urethrectomy on the basis 
of their primary tumor [6,7]. Similarly, OBS is relatively 
contraindicated in patients with significant benign ure-
thral pathology, such as recurrent urethral strictures. 
Although prostate tumor involvement in male patients and 
bladder neck involvement in female patients are risk fac-
tors for urethral recurrence [8,9], OBS is possibly indi-
cated, provided that intraoperative frozen section analysis 
of the urethral margin is without evidence of tumor [9-11].
　With accumulated experience in the OBS procedure, ad-
vanced tumor stage is not an absolute contraindication for 
OBS. In a proportion of patients with locally advanced or 
node-positive disease, long-term survival can be achieved 
with a low incidence of pelvic recurrence (range, 10-13%) 
through RC and thorough pelvic lymph node dissection 
[12-14]. Thus, OBS can be performed in these patients with 
anticipated good results. Furthermore, it was reported 
that even in the presence of recurrent disease, most pa-
tients can achieve normal neobladder function until death 
[14]. However, if tumor involvement to adjacent organs or 
extensive lymph node involvement is suspected, an ileal 
conduit rather than OBS is preferable for prompt adjuvant 
therapy [15].
　Notably, old age is not a contraindication for OBS. Older 
patients, as part of the informed consent, need to be aware 
that they have a greater incidence of enuresis or nocturnal 
incontinence than do younger men, but age by itself should 
not be a contraindication. In this context, physiologic rath-
er than chronologic age must be taken into consideration 
[7].
INTRAOPERATIVE CONSIDERATIONS
1. Positive urethral margin and lymph node metastasis
If the tumor is located near the bladder neck in females or 
involves the prostatic urethra in males, intraoperative fro-
zen section analysis of the distal urethral margin may be 
necessary. Because a positive urethral margin warrants 
total urethrectomy, all patients should be informed that di-
version to the skin via an ileal conduit may be necessary 
owing to unexpected tumor extent, and an appropriate sto-
ma site should be marked on the abdominal wall before-
hand.
　The incidence of lymph node metastasis at RC has been 
reported to be 14% to 32% [16-19]. Although intraoperative 
frozen section analysis for removed lymph nodes is not our 
routine practice, we do frozen section analysis in cases of 
palpable or grossly enlarged lymph nodes. If the results re-
veal positive lymph nodes, we do frozen section analysis for 
all lymph node specimens removed through meticulous 
lymph node dissection. In our practice, OBS can be per-
formed in patients with minimal nodal disease, whereas 
ileal conduit is preferable in patients with extensive lymph 
node involvement for prompt adjuvant therapy.
2. Ureterointestinal anastomosis: refluxing or nonreflux-
ing?
One of the important goals of urinary diversion is preserva-
tion of renal function. The necessity of reflux prevention at 
a ureteroileal anastomosis is controversial [3,7,20-22]. 
Advocates for antireflux anastomosis reported that, on the 
basis of animal experiments, refluxing anastomosis was 
more commonly associated with reflux and pyelonephritis 
and subsequent renal function deterioration [23]. However, 
previous studies have shown that that the need for reflux 
prevention differs depending on the urinary diversion 
method. Although conduits are not always low-pressure 
systems [24,25], often due to obstruction at the level of the 
fascia immediately superficial to the external oblique mus-
cle, OBS is associated with consistently low intra-reservoir 
pressure through bowel detubularization [26] and simulta-
neous pressure increases in the neobladder, abdomen, and 
renal pelvis during the Valsalva maneuver [21]. Mean-
while, many studies have reported that the risk of anasto-
mosis stricture is significantly higher in nonrefluxing tech-
niques than in direct refluxing anastomosis [2,21,22,27]. 
Hautmann et al reported that simple end-to-side, freely re-
fluxing anastomosis to an afferent limb of a low-pressure Korean J Urol 2011;52:233-240
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orthotopic reconstruction, in combination with regular 
voiding and close follow-up, has the lowest overall compli-
cation rate [4]. Consistent with these reports, we have re-
ported no significant difference in functional or radio-
graphic changes between the refluxing and nonrefluxing 
types of OBS [28], and although reflux was more common 
in refluxing anastomosis in postoperative voiding cystour-
ethrography, the development of reflux after RC does not 
significantly alter renal function regardless of its severity 
[29]. 
　Integrating the published results and our experience, we 
believe that freely refluxing ureteroileal anastomosis is a 
safe and easy method for OBS. 
3. Short mesentery 
Tension-free anastomosis between a neobladder and the 
distal urethra may be difficult in patients with a short 
mesentery. In this situation, anastomosis can be per-
formed under a more flexed position to minimize tension. 
If this is not enough, dissecting the mesentery to a more 
proximal site or making multiple, small incisions in the 
mesentery can lengthen the mesentery. Several inves-
tigators have suggested neourethral tube modification 
methods for adding extra length to reach the urethra. For 
example, Rawal et al reported a modification of the Studer 
neobladder method, the ‘pitcher pot’ ileal neobladder, 
which is the formation of a tube or neourethra by use of a 
part of the ileal wall, consequently providing extra length 
for anastomosis without tension [30]. However, note that 
this method is associated with urinary retention and an ob-
structive voiding pattern.
4. Ureteral stents and cystostomy 
Placement of a ureteral stent at a ureteroileal anastomosis 
depends on the surgeon’s preference. Most surgeons use a 
ureteral stent at a ureteroileal anastomosis and then re-
move the stent with the Foley catheter after cystography 
at 2-3 weeks postoperatively. In our experience, a ureteral 
stent is not necessarily needed in refluxing anastomosis, 
whereas it is helpful to prevent anastomosis obstruction in 
antirefluxing anastomosis.
　Placement of a cystostomy into the neobladder is useful 
for postoperative manual irrigation and monitoring of the 
voiding pattern after Foley catheter removal. However, in 
our experience, use of a large-sized (22-24 Fr) double-lu-
men catheter or nephrostomy catheter without cystostomy 
is enough.
POSTOPERATIVE PROBLEMS AND SOLUTIONS
1. Postoperative ileus
Ileus following RC is one of the most frequent postoperative 
complications that cause delayed recovery and increased 
hospital stay [31-34]. Ileus was noted in 4-23% of patients 
undergoing RC [32-35]. Chang et al reported that increased 
blood loss during surgery and the presence of major compli-
cations were significant predictors for ileus [32]. Several 
perioperative managements should be considered to re-
duce postoperative ileus. Because the perception of pain is 
an acknowledged promoter of ileus [36], adequate intra-
operative and postoperative pain control is important. 
Hypovolemia during surgery is also associated with an in-
creased risk of postoperative ileus [31,32]. Thus, timely 
and adequate hydration with colloids or blood transfusions 
is crucial after exenteration, when blood loss exceeds 10% 
of the estimated total blood volume [37]. Additionally, early 
postoperative provision of artificial nutrients, in the form 
of both total parenteral nutrition and enteral nutrition, has 
shown beneficial effects in preventing postoperative ileus 
[37].
　Although nasogastric tubing is helpful intraoperatively 
to obtain bowel decompression, routine postoperative na-
sogastric decompression may be unnecessary. For exam-
ple, recent studies have shown that bowel resection can be 
performed safely without postoperative nasogastric tub-
ing both in general surgery cases and in radical cystectomy 
[35,38]. Two meta-analyses including over 4,000 cases con-
cluded that routine postoperative nasogastric decom-
pression was unnecessary and was associated with a high-
er incidence of pulmonary complications than selective na-
sogastric decompression [39,40]. Meanwhile, two recent 
studies reported that gum chewing stimulates bowel mo-
tility in patients undergoing radical cystectomy with uri-
nary diversion [41,42].
2. Urinary tract infection
Contrary to normal urothelium, which has inhibitory ac-
tion against bacterial adherence, bowel epithelium lacks 
inhibitory action against bacterial adherence. It has been 
reported that about 51-67% of patients with orthotopic neo-
bladder have a positive urine culture [43-45]. Compared 
with other types of urinary diversion, few studies have in-
vestigated urinary tract infection (UTI) in patients with or-
thotopic neobladder. In a study by Wullt et al, E. coli, 
Klebsiella pneumoniae,  Pseudomonas aeruginosa, and 
Enterococcus faecalis were frequently detected pathogens, 
and bacterial colonization was strongly correlated with re-
sidual urine [44]. However, all patients in this study were 
asymptomatic. In another study by Wood et al, the overall 
rate of UTI was 39%, and 12% of patients had urosepsis 
[43]. The authors suggested that prophylactic antibiotics 
are recommended in patients with recurrent UTI but that 
treating a positive urinary culture in the absence of specific 
voiding symptoms is not advocated. As such, the need for 
antibiotic treatment and the clinical significance of bacter-
iuria in patients with OBS are controversial. In our experi-
ence at the Asan Medical Center, the most frequent uropa-
thogens associated with perioperative pyelonephritis and 
febrile UTI are Enterococcus faecalis, followed by methi-
cillin-resistant Staphylococcus aureus. Because Entero-
coccous species are mostly susceptible to ampicillin, we use 
prophylactic antibiotics for 4 weeks postoperatively. 
　After RC, patients with neobladders commonly have 
chronic bacteriuria, which is fairly steady over many years Korean J Urol 2011;52:233-240
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[43,44,46,47]. Although ileal neobladders lack the native 
immunologic defenses of the native bladder mucosa and 
bacterial colonization may progress to invasive tissue-level 
infection, all investigators recommend against long-term 
prophylactic antibiotic therapy for patients with asympto-
matic bacteriuria to reduce the development of drug-re-
sistant species and to minimize cost and drug-related ad-
verse effects. Additional studies are needed so that con-
clusions can be made regarding UTI in patients with ortho-
topic neobladder.
3. Urinary continence 
Continence after OBS is affected by multiple factors, in-
cluding the size and configuration of the neobladder, ure-
thral length, patient age and mental status, intact pelvic 
nerve supply to the rhabdosphincter, completeness of void-
ing, and the presence or absence of bacteriuria [48-50]. 
Continence improves over time during the initial 6 to 12 
months postoperatively as the compliance of the diversion 
increases [46,48]. In addition, after surgery, patients learn 
to void by performing a Valsalva maneuver in coordination 
with relaxation of the pelvic floor, resulting in spontaneous 
voiding to empty the diversion. Daytime continence is ach-
ieved earlier than nighttime continence [2]. At postopera-
tive 1 year, the overall rate of daytime continence, defined 
as totally dry or the use of 1 pad per day, is approximately 
85% to 90% [1,47,50-53]. Regarding the relationship be-
tween neobladder configuration and continence, Nesrallah 
et al found that at 3 to 6 months postoperatively, daytime 
incontinence and enuresis were more common in elongated 
ileal neobladders than in spherical neobladders but the re-
sults were the same by 1 year in both groups [53]. In that 
study, at 1 year, spherical neobladders tended to enlarge 
to a greater capacity and to have a higher prevalence of 
postvoid residual urine volume over 100 ml and a greater 
need for catheterization [53]. Thus, surgeons should be 
careful to not make the initial volume of a spherical neo-
bladder too large. On the other hand, decreased functional 
urethral length after surgery [48] or decreased urethral 
sensitivity at the membranous urethra in men [54] was re-
ported to be associated with daytime incontinence. Day-
time continence rates may decrease 4 to 5 years postopera-
tively, partly because of decreased tone of the urethral 
sphincter with advanced age [55]. Persistent severe incon-
tinence after OBS may be treated by periurethral collagen 
injection [56] or definitive placement of a urethral sling or 
artificial urinary sphincter.
　In contrast with daytime continence, some degree of noc-
turnal leakage is a constant finding in most reports despite 
a technically sound operation [48]. Most series report a 
prevalence of nighttime leakage of 20% to 50% even after 
1 year postoperatively [57-60]. Similar to daytime incon-
tinence, nighttime incontinence resolves as the functional 
capacity of the neobladder increases. Rates of complete 
nighttime continence without any pads are reported to be 
45% to 65% [60,61]. In a study based on urodynamic study 
[58], patients with enuresis had higher pressures, max-
imal volumes, postvoid residual urine volumes, and rates 
of positive urine culture, as well as lower maximal urethral 
pressures, flow rates, and compliance, than did those with-
out enuresis by univariate analysis. However, in the multi-
variate analysis, only the amplitude of uninhibited con-
tractions and increased postvoid residual volume were as-
sociated with enuresis [58]. Increased age was associated 
with a higher rate of enuresis in some series [51], whereas 
in other reports, age was not correlated [58]. For treatment 
of nighttime incontinence, patients are instructed initially 
to limit their fluid intake after the evening meal, to void be-
fore going to sleep, and to set an alarm clock to awaken and 
void once or twice during the night. Several studies re-
ported that the use of imipramine hydrochloride 25 mg at 
bedtime decreases nighttime leakage in up to 25% of pa-
tients [57,58]. However, nighttime continence can ulti-
mately be achieved with improvement of the patient’s void-
ing pattern.
4. Incomplete voiding (hypercontinence)
After OBS, incomplete emptying and so-called hypercon-
tinence requiring clean intermittent catheterization (CIC) 
is observed in 4% to 25% of males [44,50,62] and in 0% to 
53% of females with neobladders [63,64]. Thus, voiding 
dysfunction after OBS is more common in women than in 
men. Although the cause of this finding is unclear, many 
studies have suggested that the primary cause of hyper-
continence in female patients is formation of a “pouchocele” 
from lack of posterior support of the neobladder, which 
leads to angulation and obstruction of the neobladder-ure-
thra junction [64-67]. Additionally, several factors such as 
an elongated bladder neck, the neobladder outlet not lo-
cated at the most caudal portion of the reservoir, a dysfunc-
tional bladder neck, inadequate pelvic floor relaxation, and 
excessive reservoir volume are suggested to be the cause 
of hypercontinence [62,65,67].
　Although CIC is the best method for treatment of hyper-
continence, compliance of male patients is low compared 
with female patients. In our experience, high doses of an 
alpha-blocker can bring subjective symptom improve-
ment, but reduction of residual urine volume is rare. To re-
duce postoperative hypercontinence, patients should 
clearly understand the principle that lowering outlet re-
sistance is crucial for complete emptying. Because increas-
ing intra-abdominal pressure only is not enough for void-
ing, instruction on pelvic floor relaxation through biofeed-
back, regular voiding to prevent overdistention, and regu-
lar follow-up is essential [68]. In patients who do not re-
spond to conservative management, cystoscopic evalua-
tion to exclude the presence of stricture is necessary. In ad-
dition, if hypercontinence is associated with fixed sphinc-
ter tone on urodynamic study, partial sphincterotomy may 
be helpful. In females, techniques to prevent pouchocele 
formation include urethral suspension, placement of the 
omentum into the space posterior to the pouch, and suspen-
sion of the vaginal fornices to the Cooper ligament [69,70].Korean J Urol 2011;52:233-240
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TABLE 2. Overview of studies that assessed health-related QoL after radical cystectomy and NB or IC
References Year
No. of 
patients
Instrument Time of 
QoL 
assessment
Main findings
Name
General or 
disease-specific
Vali-
dated
Dutta et al 
[83]
2002 NB (49)
IC (23)
SF-36 &
FACT-G
General
General
Yes
Yes
2.7  yr No differences in SF-36 (multivariate 
analysis)
No differences in FACT-G
Hara et al 
[85]
2002 NB (48)
IC (37)
SF-36 General Yes NB - 46 mo
IC -131 mo
No differences in any scale score, all pa-
tients generally satisfied with overall 
health QoL
Sogni et al 
[86]
2008 NB (32)
IC (53)
QLQ-C30 &
QLQ-BLM
General (cancer)
Specific (bladder 
cancer)
Yes
Yes
42 mo No differences in elderly (≥75 yrs) pa-
tients
Hobisch et al 
[87]
2001 NB (69)
IC (33)
QLQ-C30 &
Self-designed 
questionnaire
General (cancer)
Specific (urinary 
diversion)
Yes
No
NB - 28.3 mo
IC -55.5 mo
NB better in all domains, NB with more 
travel＋Leisure＋more likely to recom-
mend to friend
Porter et al 
[89]
2005 -
Systematic review of the literature
- Evidence III/B (retrospective, cross-sec-
tional) in most studies. Any form of uri-
nary diversion is not superior to another
in QoL outcomes
Gerharz et al 
[90]
2005 -
QoL: quality of life, NB: neobladder, IC: ileal conduit, FACT-G: Functional Assessment of Cancer Therapy-General, QLQ-C30: EORTC
instruments QoL questionnaire C30, QLQ-BLM: QLQ-muscle-invasive bladder cancer module
5. Mucus production 
The bowel mucosa secretes mucus made up of a glyco-
protein core [71], and about 35 g/day of mucus is produced 
in continent urinary diversions [72]. Therefore, from the 
first postoperative day, indwelling catheters must be care-
fully irrigated to prevent initial mucous buildup within the 
neobladder [46,73]. Because a sudden increase in mucous 
production may be an early sign of urinary infection [74], 
it is worthy of notice. Patients with good voiding and com-
plete emptying usually pass the mucus spontaneously in 
the urine, whereas patients with incomplete emptying and 
those performing CIC may need to irrigate the neobladder 
to remove the retained mucus. 
　Ileal mucosa incorporated into urinary diversion ap-
pears to atrophy over time when exposed to urine [75]. 
However, it takes more than 4 years for ileal mucosa to lose 
its absorptive and secretive functions and acquire the func-
tion of a urinary reservoir [48,76]. Thus, during the period 
for structural and ultrastructural changes to the ileal mu-
cosa, regular monitoring of the voiding pattern and com-
plete emptying is necessary. Once a large mucous plug is 
formed, no drug treatment may be effective, and manual 
evacuation through a large resectoscope sheath is most 
beneficial [77]. Patients experiencing recurrent mucous re-
tention should be instructed in periodic catheter irrigation 
and mucous evacuation, and oral or instillation therapy 
with N-acetylcysteine or urea is helpful in these patients 
[71,72,78].
6. Metabolic problems
Metabolic complications of OBS are common but are gen-
erally not severe. However, when renal function is in-
sufficient or deteriorated, metabolic abnormalities can be 
problematic. Postoperative deterioration in renal function 
is most commonly associated with obstruction or infection 
[79]. Meanwhile, the more ileum that is used for reservoir 
construction, the higher the incidence of postoperative 
metabolic acidosis.
　After urinary diversion, altered drug metabolism should 
be considered. Particularly, chemotherapeutic agents used 
in the treatment of bladder cancer require attention. Be-
cause methotrexate toxicity in patients with ileal conduits 
had been reported [80,81], patients with OBS who are re-
ceiving chemotherapy should be monitored closely and 
should stay well hydrated; the reservoir should be drained 
during treatment. Additionally, preservation of the termi-
nal ileum is important to prevent vitamin B12 deficiency, 
which increases with age and declining renal function. 
Because chronic vitamin B12 deficiency is insidious and 
may result in irreversible neurologic and hematologic se-
quelae, long-term monitoring for vitamin B12 is necessary 
[82].
PATIENT’S QoL
The optimal form of urinary diversion after RC in terms of 
patient QoL remains controversial. To date, more than 30 
articles have compared the impact of different types of uri-
nary diversion on patient QoL (Table 2), whereas no studies 
have examined QoL among different types of OBS. A major 
obstacle in assessing patient QoL after urinary diversion 
is the lack of a universal definition of the term “quality of 
life,” which may differ between cultures, countries, and 
study groups. In addition, a patient’s QoL is largely depen-
dent on measurement modalities (open or structured face- 
to-face interview, telephone interview, proxy rating, self- Korean J Urol 2011;52:233-240
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report, etc) [4] and the QoL questionnaire itself (validated 
questionnaire or not, generic or cancer-specific or bladder 
cancer-specific QoL instruments, etc). To minimize these 
limitations and to evaluate QoL appropriately, it is crucial 
that a neutral third party be used to carry out the studies 
and questionnaires with validity and reliability.
　Obviously, patients with neobladders have enhanced 
cosmesis and the potential for normal voiding function 
with no abdominal stoma and no need for a stomal appli-
ance. However, the assumption that OBS provides better 
QoL than ileal conduit diversion is not supported by the re-
sults of previous studies. In a study comparing QoL between 
ileal conduit and OBS with 2 validated questionnaires, the 
RAND 36-Item Health Survey (SF-36) and the Functional 
Assessment of Cancer Therapy-General (FACT-G), young 
age and neobladder type were associated with higher QoL 
scores in 5 of the 9 SF-36 domains, but such significance 
favoring neobladder was not observed in the multivariate 
analysis with adjustment for age [83]. In this study, there 
were no significant differences in QoL between the two 
groups on the FACT-G. Similarly, no difference was ob-
served in other studies comparing QoL between ileal con-
duit and orthotopic neobladder by use of the SF-36 ques-
tionnaire [84,85] and EORTC instruments QoL ques-
tionnaire C30 (QLQ-C30) and QLQ-muscle-invasive blad-
der cancer module (QLQ-BLM) [86]. To date, the superi-
ority of OBS has been shown in only one study by Hobisch 
et al [87] in which patients with neobladders scored sig-
nificantly better on the QLQ-C30 in all functional domains 
(role–physical, role–emotional, cognitive, and social) than 
did patients with conduits. However, a systematic review 
of the published literature [88-90] was insufficient to con-
clude that any form of urinary diversion is superior to an-
other on the basis of QoL outcomes.
　In fact, patients with an ileal conduit may discover that 
life with an ileal conduit is better than anticipated in terms 
of satisfaction, whereas patients with OBS may be dissat-
isfied if they anticipate the internal reservoir to function 
as well as the original bladder [48]. Thus, regarding patient 
satisfaction and QoL, it is important that the clinician pro-
vide a detailed explanation about the physical and lifestyle 
changes that occur after OBS. We believe that with this de-
tailed preoperative education and discussion, most patients 
undergoing OBS can enjoy good QoL and have an improved 
self-image without an external urostomy appliance.
CONCLUSIONS
Orthotopic bladder substitution following cystectomy can 
provide excellent outcomes in patients who are highly mo-
tivated and carefully selected. To achieve this goal, sur-
geons should be familiar with possible pitfalls and their sol-
utions as well as with adequate operative technique. When 
performed properly, orthotopic continent diversion offers 
good QoL with few long-term complications. Therefore, we 
believe it is the best option for the majority of patients re-
quiring cystectomy.
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